GLPwatch
Mounjaro vs Zepbound
Drug comparison
Last updated 2026-05-28 15:46 UTCMounjaro and Zepbound are both injectable medications made by Eli Lilly that contain the same active ingredient, tirzepatide. Mounjaro is FDA-approved to treat type 2 diabetes, while Zepbound is approved for obesity and obstructive sleep apnea. Both are taken as a subcutaneous injection, meaning they are injected under the skin.
AI summary of the sources below.
| Mounjaro | Zepbound | |
|---|---|---|
| Active ingredient | tirzepatide | tirzepatide |
| Manufacturer | eli-lilly | eli-lilly |
| Route | subcutaneous injection | subcutaneous injection |
| FDA-approved for | type 2 diabetes | obesity, obstructive sleep apnea |
| Label updated | 2026-04-22 | 2026-04-22 |